Recent summary of changes to the LAM
The tables below show a summary of changes to the list of approved medicines (LAM) since it was last published. The LAM is published monthly or more frequently if required.
Additions
| Dimeticone
spray (e.g. Nitwits All-In-One) |
| Glofitamab injection 2.5 mg/2.5 mL, 10 mg/10 mL |
| Romidepsin injection 10 mg |
| Rozanolixizumab injection 280 mg/2 mL |
| Sodium alginate + Magnesium alginate (225 mg + 87.5 mg per sachet) |
| Somapacitan injection 10 mg/1.5 mL, 15 mg/1.5 mL pen device |
| Tezepelumab injection 210 mg/1.91 mL |
Amendments
| Botulinum
toxin type A injection 100 units |
| Clindamycin cream 2% |
| Clostridium botulinum type A toxin-haemagglutinin complex injection 300 units, 500 units |
| Entecavir tablet 500 microgram |
| Sodium Alginate + Bicarbonate + Calcium Carbonate Oral Liquid (500 mg/10 mL + 213 mg/10 mL + 325 mg/10 mL , 500 mg/10 ml + 267 mg/10 ml + 160 mg/10 ml) |
Deletions
| Aluminium hydroxide + Magnesium trisilicate + Magnesium hydroxide Oral liquid (250 mg/5 ml + 120 mg/5 ml + 120 mg/5 ml) |
| Epoetin alfa 1000 units/0.5mL injection, 2000 units/0.5mL
injection, 3000 units/0.3mL injection, 4000 units/0.4mL injection, 5000
units/0.5mL injection, 6000 units/0.6mL injection, 8000 units/0.8mL
injection, 10 000 units/mL injection, 20 000 units/0.5mL injection, 40 000
units/1mL injection (pending depletion of stock) |
| Hedrin (dimeticone 4%) – gel, 100mL |
| Malathion Lotion 0.5% |
| Permethrin Lotion 5% |
